Galderma Introduces Cetaphil AM/PM Antioxidant Serums, a New Science-Driven Defense and Recovery Sys

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD) today announced Cetaphil, the dermatologist-recommended brand trusted by millions with sensitive skin, is launching its new Cetaphil AM/PM Antioxidant Serums, a breakthrough daily system clinically designed to defend skin by day and support accelerated repair by night for sensitive, stressed skin.

While antioxidant serums are a cornerstone of modern skincare, the category has largely been developed without sensitive skin in mind. Despite rapid growth, many formulations prioritize potency over skin compatibility, narrowing options for those who require both efficacy and tolerance. This gap is especially significant given that, globally, an estimated 78% of people report experiencing skin sensitivity4, according to research from Galderma’s Global Sensitive Skincare Faculty (GSSF). Further Galderma research demonstrates that sensitive skin exhibits 16% higher oxidative stress compared to non-sensitive skin under modern environmental conditions5. Together, these findings underscore the need for solutions designed to meet the needs of sensitive skin across ages, environments, and lifestyles.

Cetaphil’s AM/PM Antioxidant Serums were developed to address this unmet need, introducing a new approach that pairs advanced antioxidant science with formulations specifically engineered for sensitive skin, delivering performance without compromising barrier health.

Breakthrough antioxidant technology designed for sensitive skin

At the core of Cetaphil’s AM/PM Antioxidant Serums is a unique Gallic-AOX Power™ Technology, a proprietary antioxidant complex that redefines what antioxidant care can look like for sensitive skin. Combining Gallic Acid and Vitamin E, this advanced technology neutralizes free radicals more efficiently than traditional antioxidants like vitamin C, helping sensitive skin defend itself against oxidative stress without triggering irritation.

In global laboratory testing, Gallic Acid demonstrated more than twice the antioxidant efficacy of Vitamin C3, establishing a new benchmark in antioxidant performance. In global clinical evaluations, consistent use of the AM/PM system resulted in skin that is up to 7x stronger against daily stressors6, reinforcing the role of targeted antioxidant care in supporting barrier health for sensitive skin.

The technology builds on emerging research linking oxidative stress, lifestyle factors, and barrier disruption to periods of heightened skin sensitivity, and is further supported by new research published in collaboration with Galderma’s Global Sensitive Skincare Faculty (GSSF), reinforcing the connection between oxidative stress and sensitive skin.

Each formula was co-developed with dermatologists and clinically tested on sensitive skin to ensure both efficacy and long-term tolerability. This science-led approach reflects Cetaphil’s continued focus on aligning advanced efficacy with the unique needs of sensitive skin.